Rectal cancer is the third deadliest cancer in the world. The choice of its clinical treatment plan is closely related to clinical staging, which mainly depends on preoperative MR staging. Clinical work experience has found that the MR staging obtained by the existing MR technology is often less precise and often higher than the postoperative pathological staging. In order to solve this problem, our research has found that Amide Proton Transfer(ATP) imaging has a strong correlation with postoperative pathological staging, which can help clinicians to make a more accurate diagnosis of rectal cancer staging before surgery.
This abstract and the presentation materials are available to members only; a login is required.